Crowdonomics
All companies
LUUM logo

LUUM

Operating

Wink Robotics, Inc.

Industrial & Manufacturing · Oakland, DE · Founded 2017

Stunning lashes, surprisingly fast

Post-money valuation ⓘ
$48.0M
As of Apr 2023 · from Reg CF Offering (2022) · pre-money + amount raised, not a traded price
Total raised
$33,237,798
Crowd $463K · Private $32.8M · 10 rounds since 2017
Latest share price
$0.4054
Rule 506(c) · Series Seed-1 Preferred Stock 2022 · May 2022 offering price · down round

Financials

FY2019–FY2023 · from SEC filings · hover any figure for its source
$0
−$2.8M
2019
$0
−$2.7M
2020
$6K
−$3.3M
2021
$6K
−$3.3M
2022
$2K
−$3.1M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2019 reviewed*
FY2020 reviewed*
FY2021
FY2022
FY2023
Income statement
Revenue
$0
$0
$6,166
$6,166
$2,470
Cost of goods sold
$0
$0
$87,756
$87,756
$116,473
Gross margin
—
—
-1323%
-1323%
-4615%
Net income
-$2,790,676
-$2,738,287
-$3,255,515
-$3,255,515
-$3,079,441
Taxes paid
$1,054
$800
$800
$800
$800
Balance sheet
Cash
$1,922,834
$2,478,413
$670,810
$670,810
$762,211
Accounts receivable
$0
$0
$0
$0
$0
Total assets
$4,227,273
$4,871,422
$3,403,767
$3,403,767
$4,759,407
Short-term debt
$87,424
$486,149
$2,030,990
$2,030,990
$1,673,550
Long-term debt
$750,000
$568,003
$533,333
$533,333
$962,299
Total liabilities
$837,424
$1,054,152
$2,564,323
$2,564,323
$2,635,849
Other
Headcount
—
12
14
6
6

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$23.3M
pre-money
$48.0M
pre-money
Reg CF · Common · Nov 2021
Reg CF · Common · Jul 2022

Blue bars are the pre-money valuation the company stated for a priced round.

Share price over rounds

$0.66$0.33$0.4054
May 2020May 2022
Round offering price or verified disclosed saleDisclosed sale, unverified or year-onlyDown round · May 2022 (-38.6%)

Disclosed sales come from the issuer's own filings (prior-offering lines, audited-statement notes) and are amount ÷ securities sold. A down round is a firm point more than 25 % below the previous firm point of the same share class on a comparable basis; the comparison ignores unverified and year-only lines.

Fundraising history

Raised $15.8MInvestors 57
Raised $0Post-money $48M
Raised $800.1KInvestors 9
Raised $463.3K / $1.1MInvestors 257Post-money $24M
Raised $5.1MInvestors 7
Raised $1.7MInvestors 14

Team

7 people
Kurt Amundson
Vice President, Engineering and Co-founder

Kurt is a recognized pioneer in robotics that interact directly with the human body, with over a decade of experience leading teams focused on these innovations. An expert in the design of complex mechatronic systems, he previously led the development of Ekso Bionics’ next-generation medical product – a wearable exoskeleton that helps stroke survivors relearn how to walk. He has 19 US patents granted and a number of pending applications in the US and worldwide Ph.D. ME, UC Berkeley MS ME, UC Berkeley BS ME, Washington University in St. Louis

Lynn Heublein
Chairwoman and Co-Founder

Lynn is the leading US entrepreneur in aesthetics, having helmed medi-spa chain, Skin Spirit for over 10 years (growing it to become the #1 reseller for Allergan’s Botox). Skin Spirit is renowned for innovating the category, providing cosmetic treatments in a welcoming and luxurious, non-clinical setting. Prior, she held leadership positions at Hearme.com, Catapult Entertainment, and Procter & Gamble. MBA, Stanford BS Engineering, UW

Nathan Harding
CEO, Director, and Co-founder

Nate is a veteran robotics pioneer, having co-founded and taken public Ekso Bionics, as a co-inventor of the company’s founding technology. He served as CEO three times, the last time including 2 years as a public company, and he raised over $100M in a difficult technology space. Prior, he led teams in developing high-speed automation equipment, including the world’s fastest offshore-pipeline welding system, optical-fiber draw-tower take-up, optical-fiber proof-testing machine, and semiconductor FOUP buffer. MS ME, UC Berkeley BS ME and Economics, Carnegie Mellon

Rachel Gold
Chief Marketing Officer & Co-founder

Rachel is a seasoned brand and product strategy leader, having led the strategy disciplines at two premiere advertising & digital experience agencies: Muh-Tay-Zik Hof-fer and Elephant. Her expertise spans brand-positioning & communications, human-centered product design, consumer insights research, and marketing platform strategy / tactics. Prior, she held leadership positions in technology product development, most recently overseeing Adobe’s transformative eCommerce conversion to the Creative Cloud subscription model. BA, Harvard – English Literature & Language MBA, California College of the Arts – Specialist in Design Thinking for Innovation,

/s/ Nathan Harding
CEO
Joanne Chen
Director

Joanne Chen is a General Partner at Foundation Capital and has served on many boards, including TubiTV (acquired by Fox for $500m), Mya (acquired by Stepstone), EraDB, Tonkean, SafelyYou, and Watchful. Prior she worked at Cisco Systems, Jefferies & Company, and Probitas Partners. MBA, University of Chicago BS Electrical Engineering, UC Berkeley

Robert Siegel
Director

Robert Siegel is a lecturer in management at the Stanford University Graduate School of Business. He is also a general partner at XSeed Capital, a venture partner at Piva Capital, and sits on many boards. Prior, Robert held leadership positions at GE Security and Pixim, and was cofounder & chief executive officer of Weave Innovations Inc. (acquired by Kodak). MBA, Stanford BA, UC Berkeley

Names and titles as disclosed on StartEngine, SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFiled Form C-TR (terminated reporting)

Filed 3 of 5 annual reports (FY2021–FY2025)

257 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

  • Form C-TRMay 2, 20250001714989-25-000001
    EDGAR
  • Form D/ANov 13, 20240001714989-24-000002
    EDGAR
  • Form DAug 16, 20240001714989-24-000001
    EDGAR
  • Form C-ARApr 19, 20240001477932-24-002248
    EDGAR
  • Form C-WApr 25, 20230001477932-23-002849
    EDGAR
  • Form C-ARApr 25, 20230001477932-23-002871
    EDGAR
  • Form DAug 1, 20220001477932-22-005514
    EDGAR
  • Form CJul 13, 20220001477932-22-004991
    EDGAR
Source: ManualCIK 0001714989DEShare price $1.10

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.